Rare Insights

Exploring the ideas, innovations, and individuals shaping the future of rare disease.

Using PICO to Build Stronger Evidence in Rare Disease Advocacy

Supporting structured, independent patient input in the EU JCA era The European Joint Clinical Assessment (JCA) is[…]

How Digital Patient Insights Can Strengthen Your EU HTA Submission

The EU Joint Clinical Assessment (JCA) represents a significant shift in the regulatory landscape for companies developing[…]

Why Patient Voices Are Critical for EU Joint Clinical Assessment (JCA) Now

The European Union is in the midst of a transformative shift toward a harmonized Health Technology Assessment[…]

Making Patient Partnership a Reality in EU Joint Clinical Assessment (JCA)

Introduction: As the EU’s Joint Clinical Assessment (JCA) system rapidly evolves, patient involvement is no longer a[…]

Early Access Strategies to Boost EU Joint Clinical Assessment (JCA) Readiness

Early Access – A Strategic Edge for JCA Readiness As the EU Joint Clinical Assessment (JCA) framework[…]

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept